Clinical Trials Directory

Trials / Terminated

TerminatedNCT02767856

Regimens of Intermittent Occlusion Therapy for Amblyopia in Children

Intense vs Standard Regimens of Intermittent Occlusion Therapy for Unilateral Moderate Amblyopia in Children

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Salus University · Academic / Other
Sex
All
Age
3 Years – 8 Years
Healthy volunteers
Accepted

Summary

This study is designed to answer the question: What if the Intermittent Occlusion (IO-therapy) glasses were prescribed all day (12-hours) in which the total time of treatment only took 4 weeks instead of the current treatment time (4 hours) in which it takes 12 weeks? Children aged 3- to 8-years with untreated moderate unilateral amblyopia will be enrolled and randomized into 2 groups: 1) Intense 12-hour IO-therapy Group for 4 weeks treatment; or 2) Standard 4-hour IO-therapy glasses Group for 12 weeks treatment.

Conditions

Interventions

TypeNameDescription
DEVICEIO-therapy Glasses

Timeline

Start date
2016-09-01
Primary completion
2021-05-30
Completion
2021-05-30
First posted
2016-05-10
Last updated
2022-07-25
Results posted
2022-07-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02767856. Inclusion in this directory is not an endorsement.

Regimens of Intermittent Occlusion Therapy for Amblyopia in Children (NCT02767856) · Clinical Trials Directory